ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,888, issued on July 14, was assigned to AB2 BIO SA (Lausanne, Switzerland).
"IL-18 binding protein (IL-18BP) and antibodies for treating inflammatory diseases" was invented by Greg Del Val (Rolle, Switzerland) and Eduardo Schiffrin (Crissier, Switzerland).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides means and methods for treating Interleukin 18 (IL-18)-associated diseases and disorders. In particular, the present invention discloses antibodies specific for free IL-18 and IL-18 Binding Protein (IL-18BP) for use in such treatments and for the diagnosis of the diseases and disorders."
The patent was filed on Feb. 8, 202...